Institutional Ownership
Ascentage Pharma Group Intl
CUSIP 04390B105SPONSORED ADSAAPGQ1 2026
Institutional Holders
7
13F filers
Shares Held
30.2K
Aggregate institutional
Institutional Value
$721.7K
Q1 2026
Net New Holders
-5
0 new · 5 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions0
Increased2
Decreased3
Sold out5
Institutional Holders
7 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 16.1K | $383.3K | −670 | Reduced |
| 2 | Xy Capital Ltd | 13.0K | $310.6K | −614 | Reduced |
| 3 | Tower Research Capital LLC (Trc) | 518 | $12.4K | +288 | Added |
| 4 | Morgan Stanley | 498 | $11.9K | +345 | Added |
| 5 | Ubs Group AG | 124 | $3.0K | −4.1K | Reduced |
| 6 | Eversource Wealth Advisors, LLC | 24 | $573 | 0 | Held |
| 7 | Royal Bank Of Canada | 6 | $0 | 0 | Held |